Austar Lifesciences Limited (HKG:6118)

Hong Kong · Delayed Price · Currency is HKD

0.7200

-0.0300 (-4.00%)

Jun 18, 2026, 3:54 PM HKT

4.35% (1Y)

Market Cap	369.06M
Revenue (ttm)	1.70B +2.0%
Net Income	37.62M +110.2%
EPS	0.07 +110.2%
Shares Out	512.58M
PE Ratio	9.81
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	44,000
Open	0.7400
Previous Close	0.7500
Day's Range	0.7200 - 0.7400
52-Week Range	0.6500 - 1.9700
Beta	0.83
Analysts	Strong Buy
Price Target	5.00 (+594.44%)
Earnings Date	Aug 26, 2026

About Austar Lifesciences

Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. The company also offers clean utility equipment and chemical pharmaceutical preparation systems; bioprocess equipment and systems; clean room, automation control, ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1991

Employees 1,468

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6118

Full Company Profile

Financial Performance

In 2025, Austar Lifesciences's revenue was 1.53 billion, an increase of 2.02% compared to the previous year's 1.50 billion. Earnings were 33.81 million, an increase of 110.24%.

Financial numbers in CNY Financial Statements